Dana-Farber Cancer Institute - Medicine

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Non-small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• IMM60 and Pembrolizumab in Melanoma and NSCLC — Stopped early